Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Torrado M, Petrovna A, Sorokin AS, Grishina EA, Ryzhikova KA, Bedina IA, Buzik OZ, Chumakov EM, Savchenko LM, Brun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Pharmacogenomics. 2020 Jan;21(2):111-123. doi: 10.2217/pgs-2019-0019. Pharmacogenomics. 2020. PMID: 31957548
Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
Zastrozhin MS, Skryabin VY, Smirnov VV, Petukhov AE, Pankratenko EP, Zastrozhina AK, Grishina EA, Ryzhikova KA, Bure IV, Golovinskii PA, Koporov SG, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Gene. 2020 May 20;739:144513. doi: 10.1016/j.gene.2020.144513. Epub 2020 Feb 26. Gene. 2020. PMID: 32112986
Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder.
Zastrozhin MS, Skryabin VY, Petukhov AE, Torrado MV, Pankratenko EP, Zastrozhina AK, Grishina EA, Ryzhikova KA, Shipitsyn VV, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Pharmacogenomics J. 2021 Aug;21(4):435-439. doi: 10.1038/s41397-021-00219-7. Epub 2021 Feb 19. Pharmacogenomics J. 2021. PMID: 33608663
Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Zastrozhin MS, Skryabin V, Smirnov V, Zastrozhina AK, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Psychopharmacol Bull. 2021 Jan 12;51(1):69-80. Psychopharmacol Bull. 2021. PMID: 33897064 Free PMC article.
Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Zastrozhin MS, Skryabin V, Smirnov V, Zastrozhina AK, Kaverina EV, Klepikov DA, Grishina EA, Ryzhikova KA, Bure IV, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: ryzhikova ka. Psychopharmacol Bull. 2021 Mar 16;51(2):31-42. Psychopharmacol Bull. 2021. PMID: 34092821 Free PMC article.
38 results